Eclipsebio

Executive Summary

Eclipsebio is a San Diego-based biotechnology company founded in 2015 that has established itself as a leading provider of integrated solutions for RNA therapeutic discovery and development. The company offers a comprehensive suite of design, analytics, and characterization services supporting the development of oligonucleotides, small molecules, and other RNA-targeted drugs. Serving a diverse client base ranging from academic researchers to biopharmaceutical companies, Eclipsebio is well-positioned to capitalize on the rapidly growing RNA therapeutics market. The company's expertise in RNA biology and its end-to-end service model enable it to support clients from early discovery through preclinical development, addressing a critical need in the drug development pipeline. As the RNA therapeutics field continues to expand, Eclipsebio's integrated platform and industry leadership present significant growth opportunities.

Upcoming Catalysts (preview)

• 2026Potential Series A or B funding round to expand service capabilities70% success
• TBDAnnouncement of strategic partnership with a major biopharma company60% success
• TBDLaunch of new analytical services or technology platform for RNA characterization50% success